<?xml version="1.0" encoding="UTF-8"?><COCHRANE_REVIEW DESCRIPTION="Ready for pub" DOI="10.1002/14651858.CD013437" GROUP_ID="ARI" ID="353119012302490855" MERGED_FROM="" MODIFIED="2021-11-22 16:58:20 +0000" MODIFIED_BY="z1809101144386590162364906459144" REVIEW_NO="A220" REVMAN_SUB_VERSION="5.4.1" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="2.20"><COVER_SHEET MODIFIED="2019-03-04 14:11:04 +0000" MODIFIED_BY="z1902130359143834834911551347507"><TITLE MODIFIED="2020-12-04 16:33:21 +0000" MODIFIED_BY="z1809101144386590162364906459144" NOTES="&lt;p&gt;(UK English, serial comma, notes in a Word doc)&lt;/p&gt;" NOTES_MODIFIED="2021-11-01 23:23:46 +0000" NOTES_MODIFIED_BY="z1410211803125963335549909990550">Non-corticosteroid adjuvant therapies for acute bacterial meningitis</TITLE><CONTACT><PERSON ID="z1809101144386590162364906459144" MODIFIED="2021-11-22 22:59:03 +0000" MODIFIED_BY="11557" ROLE="AUTHOR"><PREFIX/><FIRST_NAME>Jane</FIRST_NAME><MIDDLE_INITIALS/><LAST_NAME>Fisher</LAST_NAME><SUFFIX/><POSITION/><EMAIL_1>jane.fisher@med.lu.se</EMAIL_1><EMAIL_2/><URL/><MOBILE_PHONE/><ADDRESS><DEPARTMENT>Department of Clinical Sciences, Division of Infection Medicine</DEPARTMENT><ORGANISATION>Lund University</ORGANISATION><ADDRESS_1/><ADDRESS_2/><CITY>Lund</CITY><ZIP/><REGION/><COUNTRY CODE="SE">Sweden</COUNTRY><PHONE_1/><PHONE_2/><FAX_1/><FAX_2/></ADDRESS><FOOTNOTE/></PERSON></CONTACT><CREATORS MODIFIED="2021-11-22 22:59:03 +0000" MODIFIED_BY="11557"><PERSON ID="z1809101144386590162364906459144" MODIFIED="2021-11-22 22:59:03 +0000" MODIFIED_BY="11557" ROLE="AUTHOR"><PREFIX/><FIRST_NAME>Jane</FIRST_NAME><MIDDLE_INITIALS/><LAST_NAME>Fisher</LAST_NAME><SUFFIX/><POSITION/><EMAIL_1>jane.fisher@med.lu.se</EMAIL_1><EMAIL_2/><URL/><MOBILE_PHONE/><ADDRESS><DEPARTMENT>Department of Clinical Sciences, Division of Infection Medicine</DEPARTMENT><ORGANISATION>Lund University</ORGANISATION><ADDRESS_1/><ADDRESS_2/><CITY>Lund</CITY><ZIP/><REGION/><COUNTRY CODE="SE">Sweden</COUNTRY><PHONE_1/><PHONE_2/><FAX_1/><FAX_2/></ADDRESS><FOOTNOTE/></PERSON><PERSON ID="z1902130355253283113765594678812" MODIFIED="2021-11-22 22:59:03 +0000" MODIFIED_BY="11557" ROLE="AUTHOR"><PREFIX/><FIRST_NAME>Adam</FIRST_NAME><MIDDLE_INITIALS/><LAST_NAME>Linder</LAST_NAME><SUFFIX/><POSITION/><EMAIL_1>adam.linder@med.lu.se</EMAIL_1><EMAIL_2/><URL/><MOBILE_PHONE/><ADDRESS><DEPARTMENT>Department of Clinical Sciences, Division of Infection Medicine</DEPARTMENT><ORGANISATION>Lund University</ORGANISATION><ADDRESS_1/><ADDRESS_2/><CITY>Lund</CITY><ZIP/><REGION/><COUNTRY CODE="SE">Sweden</COUNTRY><PHONE_1/><PHONE_2/><FAX_1/><FAX_2/></ADDRESS><FOOTNOTE/></PERSON><PERSON ID="06949243198815337251110526175424" MODIFIED="2021-11-22 22:59:03 +0000" MODIFIED_BY="11557" ROLE="AUTHOR"><PREFIX/><FIRST_NAME>Maria Grazia</FIRST_NAME><MIDDLE_INITIALS/><LAST_NAME>Calevo</LAST_NAME><SUFFIX/><POSITION/><EMAIL_1>mariagraziacalevo@gaslini.org</EMAIL_1><EMAIL_2/><URL/><MOBILE_PHONE/><ADDRESS><DEPARTMENT>Epidemiology, Biostatistics Unit, IRCCS</DEPARTMENT><ORGANISATION>Istituto Giannina Gaslini</ORGANISATION><ADDRESS_1/><ADDRESS_2/><CITY>Genoa</CITY><ZIP/><REGION/><COUNTRY CODE="IT">Italy</COUNTRY><PHONE_1/><PHONE_2/><FAX_1/><FAX_2/></ADDRESS><FOOTNOTE/></PERSON><PERSON ID="z1902130359143834834911551347507" MODIFIED="2021-11-22 22:59:03 +0000" MODIFIED_BY="11557" ROLE="AUTHOR"><PREFIX/><FIRST_NAME>Peter</FIRST_NAME><MIDDLE_INITIALS/><LAST_NAME>Bentzer</LAST_NAME><SUFFIX/><POSITION/><EMAIL_1>peter.bentzer@med.lu.se</EMAIL_1><EMAIL_2/><URL/><MOBILE_PHONE/><ADDRESS><DEPARTMENT>Department of Anesthesiology and Intensive Care</DEPARTMENT><ORGANISATION>Lund University</ORGANISATION><ADDRESS_1/><ADDRESS_2/><CITY>Lund</CITY><ZIP/><REGION/><COUNTRY CODE="SE">Sweden</COUNTRY><PHONE_1/><PHONE_2/><FAX_1/><FAX_2/></ADDRESS><FOOTNOTE/></PERSON></CREATORS><DATES MODIFIED="2021-11-22 22:59:03 +0000" MODIFIED_BY="11557"><UP_TO_DATE><DATE DAY="4" MONTH="12" YEAR="2020"/></UP_TO_DATE><LAST_SEARCH><DATE DAY="30" MONTH="9" YEAR="2021"/></LAST_SEARCH><NEXT_STAGE><DATE DAY="30" MONTH="9" YEAR="2020"/></NEXT_STAGE><PROTOCOL_PUBLISHED ISSUE="9" YEAR="2019"/><REVIEW_PUBLISHED ISSUE="" YEAR=""/><LAST_CITATION_ISSUE ISSUE="9" YEAR="2019"/></DATES><WHATS_NEW/><HISTORY/><SOURCES_OF_SUPPORT MODIFIED="2019-03-04 14:11:04 +0000" MODIFIED_BY="z1902130359143834834911551347507"><INTERNAL_SOURCES/><EXTERNAL_SOURCES/></SOURCES_OF_SUPPORT><MESH_TERMS VERIFIED="NO"/><KEYWORDS/></COVER_SHEET><MAIN_TEXT><SUMMARY><TITLE/><SUMMARY_BODY/></SUMMARY><ABSTRACT><ABS_BACKGROUND/><ABS_OBJECTIVES/><ABS_SEARCH_STRATEGY/><ABS_SELECTION_CRITERIA/><ABS_DATA_COLLECTION/><ABS_RESULTS/><ABS_CONCLUSIONS/></ABSTRACT><BODY><BACKGROUND><CONDITION/><INTERVENTION/><THEORY/><IMPORTANCE/></BACKGROUND><OBJECTIVES/><METHODS><SELECTION_CRITERIA><CRIT_STUDIES/><CRIT_PARTICIPANTS/><CRIT_INTERVENTIONS/><CRIT_OUTCOMES><CRIT_OUTCOMES_PRIMARY/><CRIT_OUTCOMES_SECONDARY/></CRIT_OUTCOMES></SELECTION_CRITERIA><SEARCH_METHODS><ELECTRONIC_SEARCHES/><OTHER_SEARCHES/></SEARCH_METHODS><DATA_COLLECTION><STUDY_SELECTION/><DATA_EXTRACTION/><QUALITY_ASSESSMENT/><EFFECT_MEASURES/><UNIT_OF_ANALYSIS/><MISSING_DATA/><HETEROGENEITY_ASSESSMENT/><BIAS_ASSESSMENT/><DATA_SYNTHESIS/><SUBGROUP_ANALYSIS/><SENSITIVITY_ANALYSIS/></DATA_COLLECTION></METHODS><RESULTS><STUDY_DESCRIPTION><SEARCH_RESULTS/><INCLUDED_STUDIES_DESCR/><EXCLUDED_STUDIES_DESCR/></STUDY_DESCRIPTION><STUDY_QUALITY><ALLOCATION/><BLINDING/><EXCLUSIONS/><SELECTIVE_REPORTING/><OTHER_BIAS_SOURCES/></STUDY_QUALITY><INTERVENTION_EFFECTS/></RESULTS><DISCUSSION><SUMMARY_OF_RESULTS/><APPLICABILITY_OF_FINDINGS/><QUALITY_OF_EVIDENCE/><POTENTIAL_BIASES/><AGREEMENT/></DISCUSSION><CONCLUSIONS><IMPLICATIONS_PRACTICE/><IMPLICATIONS_RESEARCH/></CONCLUSIONS></BODY><ACKNOWLEDGEMENTS/><CONFLICT_OF_INTEREST/><CONTRIBUTIONS/><PRO_REV_DIFF/><PUBLIC_NOTES/></MAIN_TEXT><STUDIES_AND_REFERENCES><STUDIES><INCLUDED_STUDIES><STUDY DATA_SOURCE="SOUGHT" ID="STD-MacFarlane-1977" NAME="MacFarlane 1977" YEAR="1977"><IDENTIFIERS/></STUDY><STUDY DATA_SOURCE="SOUGHT" ID="STD-Mart_x00ed_nez-de-Cuellar-2015" NAME="Martínez de Cuellar 2015" YEAR="2015"><IDENTIFIERS/></STUDY><STUDY DATA_SOURCE="MIX" ID="STD-Molyneux-2014" NAME="Molyneux 2014" YEAR="2014"><IDENTIFIERS/></STUDY><STUDY DATA_SOURCE="SOUGHT" ID="STD-Neu-1982" NAME="Neu 1982" YEAR="1982"><IDENTIFIERS/></STUDY><STUDY DATA_SOURCE="MIX" ID="STD-Pelkonen-2011" NAME="Pelkonen 2011" YEAR="2011"><IDENTIFIERS/></STUDY><STUDY DATA_SOURCE="MIX" ID="STD-Savonius-2020" NAME="Savonius 2020" YEAR="2020"><IDENTIFIERS/></STUDY><STUDY DATA_SOURCE="SOUGHT" ID="STD-Skripchenko-2011" NAME="Skripchenko 2011" YEAR="2011"><IDENTIFIERS/></STUDY><STUDY DATA_SOURCE="SOUGHT" ID="STD-Szenborn-1994" NAME="Szenborn 1994" YEAR="1994"><IDENTIFIERS/></STUDY></INCLUDED_STUDIES><EXCLUDED_STUDIES/><AWAITING_STUDIES/><ONGOING_STUDIES/></STUDIES><OTHER_REFERENCES><ADDITIONAL_REFERENCES/><OTHER_VERSIONS_REFERENCES/><PENDING_REFERENCES/></OTHER_REFERENCES></STUDIES_AND_REFERENCES><CHARACTERISTICS_OF_STUDIES><CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO"><INCLUDED_CHAR STUDY_ID="STD-MacFarlane-1977"><CHAR_METHODS/><CHAR_PARTICIPANTS/><CHAR_INTERVENTIONS/><CHAR_OUTCOMES/><CHAR_NOTES/></INCLUDED_CHAR><INCLUDED_CHAR STUDY_ID="STD-Mart_x00ed_nez-de-Cuellar-2015"><CHAR_METHODS/><CHAR_PARTICIPANTS/><CHAR_INTERVENTIONS/><CHAR_OUTCOMES/><CHAR_NOTES/></INCLUDED_CHAR><INCLUDED_CHAR STUDY_ID="STD-Molyneux-2014"><CHAR_METHODS/><CHAR_PARTICIPANTS/><CHAR_INTERVENTIONS/><CHAR_OUTCOMES/><CHAR_NOTES/></INCLUDED_CHAR><INCLUDED_CHAR STUDY_ID="STD-Neu-1982"><CHAR_METHODS/><CHAR_PARTICIPANTS/><CHAR_INTERVENTIONS/><CHAR_OUTCOMES/><CHAR_NOTES/></INCLUDED_CHAR><INCLUDED_CHAR STUDY_ID="STD-Pelkonen-2011"><CHAR_METHODS/><CHAR_PARTICIPANTS/><CHAR_INTERVENTIONS/><CHAR_OUTCOMES/><CHAR_NOTES/></INCLUDED_CHAR><INCLUDED_CHAR STUDY_ID="STD-Savonius-2020"><CHAR_METHODS/><CHAR_PARTICIPANTS/><CHAR_INTERVENTIONS/><CHAR_OUTCOMES/><CHAR_NOTES/></INCLUDED_CHAR><INCLUDED_CHAR STUDY_ID="STD-Skripchenko-2011"><CHAR_METHODS/><CHAR_PARTICIPANTS/><CHAR_INTERVENTIONS/><CHAR_OUTCOMES/><CHAR_NOTES/></INCLUDED_CHAR><INCLUDED_CHAR STUDY_ID="STD-Szenborn-1994"><CHAR_METHODS/><CHAR_PARTICIPANTS/><CHAR_INTERVENTIONS/><CHAR_OUTCOMES/><CHAR_NOTES/></INCLUDED_CHAR><FOOTNOTES/></CHARACTERISTICS_OF_INCLUDED_STUDIES><CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY"/><CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO"/><CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO"/></CHARACTERISTICS_OF_STUDIES><QUALITY_ITEMS MODIFIED="2021-11-03 22:47:07 +0000" MODIFIED_BY="z1410211803125963335549909990550"><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2021-11-22 16:58:20 +0000" MODIFIED_BY="z1809101144386590162364906459144" NO="1"><NAME>Random sequence generation (selection bias)</NAME><DESCRIPTION><P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P></DESCRIPTION><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-09-28 13:36:20 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-MacFarlane-1977"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-09-28 14:16:25 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="YES" STUDY_ID="STD-Mart_x00ed_nez-de-Cuellar-2015"><DESCRIPTION><P>"Patients were openly randomised into three groups on the basis of a randomised number table."</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-09-29 07:52:02 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="YES" STUDY_ID="STD-Molyneux-2014"><DESCRIPTION><P>"Randomization was computer generated in permuted blocks of 12"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-10-01 18:18:18 +0000" MODIFIED_BY="06949243198815337251110526175424" RESULT="YES" STUDY_ID="STD-Neu-1982"><DESCRIPTION><P>Participants were randomised according to a "list of random numbers".</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-09-29 08:19:26 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="YES" STUDY_ID="STD-Pelkonen-2011"><DESCRIPTION><P>"A randomisation sequence for 1000 patients was generated by people independent of the study in Luanda. By means of a table of random numbers in blocks of 20, the patients were allocated equally (1:1:1:1) to four treatment groups"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-10-01 18:18:18 +0000" MODIFIED_BY="06949243198815337251110526175424" RESULT="YES" STUDY_ID="STD-Savonius-2020"><DESCRIPTION><P>"Randomization was done using a computer-generated list in fixed blocks of 20, which allocated the participants in a 1:1 ratio."</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-09-29 11:29:48 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Skripchenko-2011"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-09-29 12:20:03 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Szenborn-1994"><DESCRIPTION><P>Participants were randomised according to a "randomisation scheme", no further information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2020-09-29 12:20:38 +0000" MODIFIED_BY="z1809101144386590162364906459144" NO="2"><NAME>Allocation concealment (selection bias)</NAME><DESCRIPTION><P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P></DESCRIPTION><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-09-28 13:36:34 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-MacFarlane-1977"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-09-28 14:16:45 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Mart_x00ed_nez-de-Cuellar-2015"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-09-29 07:52:24 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Molyneux-2014"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-10-01 18:18:18 +0000" MODIFIED_BY="06949243198815337251110526175424" RESULT="UNKNOWN" STUDY_ID="STD-Neu-1982"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-09-29 08:19:58 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="YES" STUDY_ID="STD-Pelkonen-2011"><DESCRIPTION><P>"Treatment allocation was concealed with sealed, sequentially numbered envelopes, in a box on the meningitis ward. After a patient had been enrolled a speciﬁc ward nurse, who otherwise did not participate in the study, opened the next envelope"</P><P>"The treatment code was kept on site in a sealed envelope, and a copy was sent to an independent data safety monitoring board."</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-10-01 18:18:18 +0000" MODIFIED_BY="06949243198815337251110526175424" RESULT="YES" STUDY_ID="STD-Savonius-2020"><DESCRIPTION><P>"The code was kept in a sealed envelope in the office of the head of the hospital, and a copy was sent to the external data and safety monitoring board (DSMB) for the interim analyses. For emergency purposes, the opening key was also kept sealed in Helsinki. The cards disclosing the specific treatment were kept in sealed envelopes in a box at the hospital ward. Once the attending physician had included a patient in the study, an otherwise non-participating study nurse opened the next envelope"</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-09-29 11:29:55 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Skripchenko-2011"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-09-29 12:20:29 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Szenborn-1994"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2019-02-18 12:59:07 +0000" MODIFIED_BY="1" NO="3"><NAME>Blinding (performance bias and detection bias)</NAME><DESCRIPTION><P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P></DESCRIPTION><QUALITY_ITEM_DATA/></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2020-09-29 12:21:42 +0000" MODIFIED_BY="z1809101144386590162364906459144" NO="7"><NAME>Blinding of participants and personnel (performance bias)</NAME><DESCRIPTION><P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P></DESCRIPTION><QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1"><NAME>All outcomes</NAME></QUALITY_ITEM_DATA_ENTRY_GROUP><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2020-09-28 13:37:16 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="NO" STUDY_ID="STD-MacFarlane-1977"><DESCRIPTION><P>Because no placebo was used, the assigned intervention could not be blinded.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2020-09-28 14:18:46 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="NO" STUDY_ID="STD-Mart_x00ed_nez-de-Cuellar-2015"><DESCRIPTION><P>Study could not be blinded due to different administration routes and lack of a placebo.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2020-09-29 07:53:21 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="YES" STUDY_ID="STD-Molyneux-2014"><DESCRIPTION><P>Study described as "double blind".</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2020-10-01 18:18:18 +0000" MODIFIED_BY="06949243198815337251110526175424" RESULT="UNKNOWN" STUDY_ID="STD-Neu-1982"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2020-09-29 08:20:56 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="YES" STUDY_ID="STD-Pelkonen-2011"><DESCRIPTION><P>Study was "double-blind", and measures were taken to ensure blinding: "Yellow infusion lines, black 50 mL syringes (for infusions), and a foil covering on the three-way stopcocks short end leading to the skin-penetrating needle (for boluses) were used to prevent distinction of the slightly yellowish cefotaxime from the colourless saline placebo. Paracetamol was given as effervescent tablets because the solution had little taste and looked like the plain-water placebo once dissolved."</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2020-10-01 18:18:18 +0000" MODIFIED_BY="06949243198815337251110526175424" RESULT="YES" STUDY_ID="STD-Savonius-2020"><DESCRIPTION><P>"Once the attending physician had included a patient in the study, an otherwise nonparticipating study nurse opened the next envelope, prepared the medications and placebos as advised, and gave the preparations for 96 hours (4 days). Thus, the patients, guardians, attending physicians, and the investigators were kept blinded to the intervention. For further masking, all children received both infusions and boluses intravenously for the entire 4-day course."</P><P>"As black syringes and yellow intravenous lines were used (with a foil covering on the 3-way stopcocks), saline could be used as a placebo preparation for cefotaxime, no matter how it was administered. The oral acetaminophen solution from effervescent tablets looked like plain water once the bubbles had disappeared. Being practically tasteless, regular drinking water served as its placebo."</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2020-09-29 11:29:58 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Skripchenko-2011"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2020-09-29 12:20:50 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="NO" STUDY_ID="STD-Szenborn-1994"><DESCRIPTION><P>No information provided, but blinding is unlikely as a placebo control was not used.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2020-09-29 12:21:49 +0000" MODIFIED_BY="z1809101144386590162364906459144" NO="8"><NAME>Blinding of outcome assessment (detection bias)</NAME><DESCRIPTION><P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P></DESCRIPTION><QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1"><NAME>All outcomes</NAME></QUALITY_ITEM_DATA_ENTRY_GROUP><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2020-09-28 13:38:08 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-MacFarlane-1977"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2020-09-28 14:19:29 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Mart_x00ed_nez-de-Cuellar-2015"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2020-09-29 07:57:50 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Molyneux-2014"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2020-10-01 18:18:18 +0000" MODIFIED_BY="06949243198815337251110526175424" RESULT="UNKNOWN" STUDY_ID="STD-Neu-1982"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2020-09-29 08:23:24 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Pelkonen-2011"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2020-10-01 18:18:18 +0000" MODIFIED_BY="06949243198815337251110526175424" RESULT="UNKNOWN" STUDY_ID="STD-Savonius-2020"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2020-09-29 11:30:45 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Skripchenko-2011"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2020-09-29 12:21:42 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Szenborn-1994"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2021-11-03 22:47:07 +0000" MODIFIED_BY="z1410211803125963335549909990550" NO="4"><NAME>Incomplete outcome data (attrition bias)</NAME><DESCRIPTION><P>Attrition bias due to amount, nature or handling of incomplete outcome data</P></DESCRIPTION><QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1"><NAME>All outcomes</NAME></QUALITY_ITEM_DATA_ENTRY_GROUP><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2020-09-28 13:38:15 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-MacFarlane-1977"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2020-09-28 14:45:03 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="YES" STUDY_ID="STD-Mart_x00ed_nez-de-Cuellar-2015"><DESCRIPTION><P>All enrolled participants are accounted for.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2020-09-29 07:58:13 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="YES" STUDY_ID="STD-Molyneux-2014"><DESCRIPTION><P>Intention-to-treat analysis with all participants accounted for</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2020-10-01 18:18:18 +0000" MODIFIED_BY="06949243198815337251110526175424" RESULT="UNKNOWN" STUDY_ID="STD-Neu-1982"><DESCRIPTION><P>No information provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2020-09-29 08:24:03 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="YES" STUDY_ID="STD-Pelkonen-2011"><DESCRIPTION><P>Intention-to-treat analysis used, and all participants accounted for.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2020-10-01 18:18:18 +0000" MODIFIED_BY="06949243198815337251110526175424" RESULT="YES" STUDY_ID="STD-Savonius-2020"><DESCRIPTION><P>Intention-to-treat analysis was used, and all participants are accounted for.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2020-09-29 11:31:40 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="YES" STUDY_ID="STD-Skripchenko-2011"><DESCRIPTION><P>All participants are accounted for.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2020-09-29 12:26:44 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Szenborn-1994"><DESCRIPTION><P>No information provided regarding the final number of participants evaluated.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2020-09-29 12:29:18 +0000" MODIFIED_BY="z1809101144386590162364906459144" NO="5"><NAME>Selective reporting (reporting bias)</NAME><DESCRIPTION><P>Reporting bias due to selective outcome reporting</P></DESCRIPTION><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-09-28 13:38:24 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-MacFarlane-1977"><DESCRIPTION><P>Study protocol was not registered, and no information is provided about<I> </I>a priori outcome definitions.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-09-28 14:45:21 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Mart_x00ed_nez-de-Cuellar-2015"><DESCRIPTION><P>Study was not registered, and information on prespecification of outcomes is not provided.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-09-29 07:58:34 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Molyneux-2014"><DESCRIPTION><P>The protocol was registered at ClinicalTrials.gov (identifier: NCT00619203). The outcome measures registered in the protocol do not match those reported in the study. Outcomes registered in the protocol were as follows.</P><P>"Primary end points are death, severe neurological sequelae, hearing loss."</P><P>"Secondary end points are audiological or neurological sequelae (according to the Denver-II developmental screening test)."</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-10-01 18:18:18 +0000" MODIFIED_BY="06949243198815337251110526175424" RESULT="UNKNOWN" STUDY_ID="STD-Neu-1982"><DESCRIPTION><P>Study protocol not available.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-09-29 08:24:45 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="YES" STUDY_ID="STD-Pelkonen-2011"><DESCRIPTION><P>Protocol was registered (ISRCTN62824827). The registered outcomes match the reported outcomes that are relevant for this review.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-10-08 07:13:19 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="YES" STUDY_ID="STD-Savonius-2020"><DESCRIPTION><P>Protocol was registered (ClinicalTrials.gov identifier: NCT01540838). Hearing impairment was registered but not reported; however, a sufficient explanation is provided for this deviation from the protocol. All other registered outcomes match the reported outcomes that are relevant for this review.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-10-07 14:46:33 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Skripchenko-2011"><DESCRIPTION><P>Study was not registered. Mortality was not reported. It is expected that studies of the efficacy of drugs in bacterial meningitis should record and include mortality as a major outcome, so the fact that it was not reported at all is suspicious.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-10-07 14:45:51 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Szenborn-1994"><DESCRIPTION><P>Study was not registered. Mortality was not reported. It is expected that studies of the efficacy of drugs in bacterial meningitis should record and include mortality as a major outcome, so the fact that it was not reported at all is suspicious.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM><QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2021-11-03 22:47:07 +0000" MODIFIED_BY="z1410211803125963335549909990550" NO="6"><NAME>Other bias</NAME><DESCRIPTION><P>Bias due to problems not covered elsewhere in the table</P></DESCRIPTION><QUALITY_ITEM_DATA><QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-08-14 14:55:15 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-MacFarlane-1977"><DESCRIPTION><P>Baseline characteristics of the groups are not described in sufficient detail to evaluate whether there were any baseline imbalances.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-08-14 14:57:09 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Mart_x00ed_nez-de-Cuellar-2015"><DESCRIPTION><P>No apparent baseline imbalances</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2020-09-29 08:13:01 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Molyneux-2014"><DESCRIPTION><P>Planned sample size in each group was not achieved. Also, baseline characteristics of the 4 groups are not described in sufficient detail to evaluate whether there were any baseline imbalances.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-08-14 14:51:31 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Neu-1982"><DESCRIPTION><P>Baseline characteristics of the groups are not described in sufficient detail to evaluate whether there were any baseline imbalances.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-08-14 14:41:56 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="YES" STUDY_ID="STD-Pelkonen-2011"><DESCRIPTION><P>No apparent baseline imbalances</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-08-14 14:49:26 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="YES" STUDY_ID="STD-Savonius-2020"><DESCRIPTION><P>No apparent baseline imbalances</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-08-14 14:54:12 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Skripchenko-2011"><DESCRIPTION><P>Baseline characteristics of the groups are not described in sufficient detail to evaluate whether there were any baseline imbalances.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY><QUALITY_ITEM_DATA_ENTRY MODIFIED="2021-08-14 14:58:18 +0000" MODIFIED_BY="z1809101144386590162364906459144" RESULT="UNKNOWN" STUDY_ID="STD-Szenborn-1994"><DESCRIPTION><P>Baseline characteristics of the groups are not described in sufficient detail to evaluate whether there were any baseline imbalances.</P></DESCRIPTION></QUALITY_ITEM_DATA_ENTRY></QUALITY_ITEM_DATA></QUALITY_ITEM></QUALITY_ITEMS><SOF_TABLES/><ADDITIONAL_TABLES/><ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2020-10-13 18:50:08 +0000" MODIFIED_BY="06949243198815337251110526175424"><COMPARISON ID="CMP-001" MODIFIED="2021-11-05 07:13:27 +0000" MODIFIED_BY="z1410211803125963335549909990550" NO="1"><NAME>Paracetamol for acute bacterial meningitis</NAME><DICH_OUTCOME CHI2="0.6999174778776706" CI_END="1.0855467831426282" CI_START="0.8122812812570095" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.93902573547029" ESTIMABLE="YES" EVENTS_1="224" EVENTS_2="238" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.03564854471616374" LOG_CI_START="-0.09029355481743229" LOG_EFFECT_SIZE="-0.02732250505063428" METHOD="MH" MODIFIED="2020-10-01 09:48:41 +0000" MODIFIED_BY="z1809101144386590162364906459144" NO="1" P_CHI2="0.7047172604502931" P_Q="1.0" P_Z="0.3950979332939186" Q="0.0" RANDOM="NO" SCALE="100.1" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="637" TOTAL_2="637" WEIGHT="100.0" Z="0.8504086570729552"><NAME>Mortality</NAME><GROUP_LABEL_1>Paracetamol</GROUP_LABEL_1><GROUP_LABEL_2>Standard treatment</GROUP_LABEL_2><GRAPH_LABEL_1>Favours paracetamol</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours std. treatment</GRAPH_LABEL_2><DICH_DATA CI_END="1.9142419066068666" CI_START="0.6855901074140522" EFFECT_SIZE="1.1455938697318007" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="21" LOG_CI_END="0.28199681957769956" LOG_CI_START="-0.1639354576054023" LOG_EFFECT_SIZE="0.059030680986148644" MODIFIED="2020-09-25 13:19:38 +0000" MODIFIED_BY="z1809101144386590162364906459144" ORDER="1" O_E="0.0" SE="0.2619428270177266" STUDY_ID="STD-Molyneux-2014" TOTAL_1="87" TOTAL_2="91" VAR="0.06861404462603862" WEIGHT="8.613725224957687"/><DICH_DATA CI_END="1.0957310664525914" CI_START="0.752311658787076" EFFECT_SIZE="0.9079269002444419" ESTIMABLE="YES" EVENTS_1="130" EVENTS_2="142" LOG_CI_END="0.03970397505385094" LOG_CI_START="-0.1236022077439408" LOG_EFFECT_SIZE="-0.04194911634504495" MODIFIED="2020-09-25 13:19:38 +0000" MODIFIED_BY="z1809101144386590162364906459144" ORDER="2" O_E="0.0" SE="0.09592686015406507" STUDY_ID="STD-Pelkonen-2011" TOTAL_1="363" TOTAL_2="360" VAR="0.009201962499017557" WEIGHT="59.8313966689371"/><DICH_DATA CI_END="1.2129637496160592" CI_START="0.7309522784745485" EFFECT_SIZE="0.9416042780748664" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="75" LOG_CI_END="0.0838478218253849" LOG_CI_START="-0.1361109758077997" LOG_EFFECT_SIZE="-0.026131576991207398" MODIFIED="2020-09-25 13:19:38 +0000" MODIFIED_BY="z1809101144386590162364906459144" ORDER="3" O_E="0.0" SE="0.1292048865433411" STUDY_ID="STD-Savonius-2020" TOTAL_1="187" TOTAL_2="186" VAR="0.01669390270667765" WEIGHT="31.554878106105203"/></DICH_OUTCOME><DICH_OUTCOME CHI2="0.791887668885663" CI_END="1.3435159051437782" CI_START="0.8044217363501932" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0395928997592565" ESTIMABLE="YES" EVENTS_1="87" EVENTS_2="85" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.12824281217245442" LOG_CI_START="-0.09451620280751191" LOG_EFFECT_SIZE="0.016863304682471266" METHOD="MH" MODIFIED="2020-10-01 09:59:32 +0000" MODIFIED_BY="z1809101144386590162364906459144" NO="2" P_CHI2="0.3735299938053199" P_Q="1.0" P_Z="0.7666601166148116" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="450" TOTAL_2="451" WEIGHT="100.0" Z="0.2967464175664611"><NAME>Any hearing loss</NAME><GROUP_LABEL_1>Paracetamol</GROUP_LABEL_1><GROUP_LABEL_2>Standard treatment</GROUP_LABEL_2><GRAPH_LABEL_1>Favours paracetamol</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours std. treatment</GRAPH_LABEL_2><DICH_DATA CI_END="1.287349755099136" CI_START="0.6552167825035994" EFFECT_SIZE="0.9184188393608074" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="41" LOG_CI_END="0.10969655473157178" LOG_CI_START="-0.18361498723151812" LOG_EFFECT_SIZE="-0.03695921624997317" MODIFIED="2020-09-28 10:35:20 +0000" MODIFIED_BY="z1809101144386590162364906459144" ORDER="4" O_E="0.0" SE="0.1722926516646679" STUDY_ID="STD-Molyneux-2014" TOTAL_1="87" TOTAL_2="91" VAR="0.02968475781764259" WEIGHT="47.56476305511091"/><DICH_DATA CI_END="1.6742015032262507" CI_START="0.7892580554470555" EFFECT_SIZE="1.149511645379414" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="44" LOG_CI_END="0.2238077275357803" LOG_CI_START="-0.10278097684993283" LOG_EFFECT_SIZE="0.06051337534292372" MODIFIED="2020-09-28 10:35:20 +0000" MODIFIED_BY="z1809101144386590162364906459144" ORDER="5" O_E="0.0" SE="0.19183982159632743" STUDY_ID="STD-Pelkonen-2011" TOTAL_1="363" TOTAL_2="360" VAR="0.036802517150110736" WEIGHT="52.435236944889084"/></DICH_OUTCOME><DICH_OUTCOME CHI2="4.9953490249832955" CI_END="2.501185507073371" CI_START="0.9784258045455759" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5643607135427549" ESTIMABLE="YES" EVENTS_1="177" EVENTS_2="131" I2="59.96275755713209" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.39814590353002177" LOG_CI_START="-0.00947210194073123" LOG_EFFECT_SIZE="0.19433690079464525" METHOD="MH" MODIFIED="2020-10-01 10:01:28 +0000" MODIFIED_BY="z1809101144386590162364906459144" NO="3" P_CHI2="0.08227617665145948" P_Q="1.0" P_Z="0.061640359869821346" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.10302537541326237" TOTALS="YES" TOTAL_1="637" TOTAL_2="637" WEIGHT="99.99999999999999" Z="1.8688739030786885"><NAME>Any neurological sequelae other than hearing loss</NAME><GROUP_LABEL_1>Paracetamol</GROUP_LABEL_1><GROUP_LABEL_2>Standard treatment</GROUP_LABEL_2><GRAPH_LABEL_1>Favours paracetamol</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours std. treatment</GRAPH_LABEL_2><DICH_DATA CI_END="3.8989471217776646" CI_START="0.7409751865940152" EFFECT_SIZE="1.6997126436781609" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="8" LOG_CI_END="0.5909473452480272" LOG_CI_START="-0.1301963352132906" LOG_EFFECT_SIZE="0.23037550501736825" MODIFIED="2020-11-01 11:40:33 +0000" MODIFIED_BY="06949243198815337251110526175424" ORDER="163367" O_E="0.0" SE="0.42360336762176803" STUDY_ID="STD-Molyneux-2014" TOTAL_1="87" TOTAL_2="91" VAR="0.17943981306050275" WEIGHT="20.296305488130702"/><DICH_DATA CI_END="1.4676608069049735" CI_START="0.9679560755693435" EFFECT_SIZE="1.1919023428614755" ESTIMABLE="YES" EVENTS_1="131" EVENTS_2="109" LOG_CI_END="0.16662569678534442" LOG_CI_START="-0.014144349892713702" LOG_EFFECT_SIZE="0.07624067344631537" MODIFIED="2020-11-01 11:40:33 +0000" MODIFIED_BY="06949243198815337251110526175424" ORDER="163368" O_E="0.0" SE="0.10618522024485398" STUDY_ID="STD-Pelkonen-2011" TOTAL_1="363" TOTAL_2="360" VAR="0.011275300998448149" WEIGHT="50.15718134839127"/><DICH_DATA CI_END="4.234901053688201" CI_START="1.297989609879737" EFFECT_SIZE="2.3445378151260505" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="14" LOG_CI_END="0.6268432677153154" LOG_CI_START="0.11327121604681825" LOG_EFFECT_SIZE="0.3700572418810668" MODIFIED="2020-11-01 11:40:33 +0000" MODIFIED_BY="06949243198815337251110526175424" ORDER="163369" O_E="0.0" SE="0.3016747653727314" STUDY_ID="STD-Savonius-2020" TOTAL_1="187" TOTAL_2="186" VAR="0.09100766406269253" WEIGHT="29.546513163478025"/></DICH_OUTCOME><DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2020-10-13 18:50:08 +0000" MODIFIED_BY="06949243198815337251110526175424" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="637" TOTAL_2="637" WEIGHT="0.0" Z="0.0"><NAME>Adverse events</NAME><GROUP_LABEL_1>Paracetamol</GROUP_LABEL_1><GROUP_LABEL_2>Standard treatment</GROUP_LABEL_2><GRAPH_LABEL_1>Favours paracetamol</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours std. treatment</GRAPH_LABEL_2><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2020-10-13 18:50:08 +0000" MODIFIED_BY="06949243198815337251110526175424" ORDER="78790" O_E="0.0" SE="0.0" STUDY_ID="STD-Molyneux-2014" TOTAL_1="87" TOTAL_2="91" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2020-10-13 18:50:08 +0000" MODIFIED_BY="06949243198815337251110526175424" ORDER="78791" O_E="0.0" SE="0.0" STUDY_ID="STD-Pelkonen-2011" TOTAL_1="363" TOTAL_2="360" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2020-10-13 18:50:08 +0000" MODIFIED_BY="06949243198815337251110526175424" ORDER="78792" O_E="0.0" SE="0.0" STUDY_ID="STD-Savonius-2020" TOTAL_1="187" TOTAL_2="186" VAR="0.0" WEIGHT="0.0"/></DICH_OUTCOME><DICH_OUTCOME CHI2="9.94982155453408E-4" CI_END="1.3588893297113647" CI_START="0.6745808748780161" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9574344640230439" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="55" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.13318408848172258" LOG_CI_START="-0.17096597570638375" LOG_EFFECT_SIZE="-0.018890943612330572" METHOD="MH" MODIFIED="2020-11-02 14:44:05 +0000" MODIFIED_BY="z1809101144386590162364906459144" NO="5" P_CHI2="0.9748362324701004" P_Q="1.0" P_Z="0.8076420304681948" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="450" TOTAL_2="451" WEIGHT="100.0" Z="0.243469086307645"><NAME>Severe hearing loss</NAME><GROUP_LABEL_1>Paracetamol</GROUP_LABEL_1><GROUP_LABEL_2>Standard treatment</GROUP_LABEL_2><GRAPH_LABEL_1>Favours paracetamol</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours std. treatment</GRAPH_LABEL_2><DICH_DATA CI_END="1.614604672200079" CI_START="0.5600060310501279" EFFECT_SIZE="0.9508881922675027" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="22" LOG_CI_END="0.2080662048721454" LOG_CI_START="-0.25180729578364525" LOG_EFFECT_SIZE="-0.021870545455749946" MODIFIED="2020-09-28 10:35:20 +0000" MODIFIED_BY="z1809101144386590162364906459144" ORDER="8" O_E="0.0" SE="0.2701319706957532" STUDY_ID="STD-Molyneux-2014" TOTAL_1="87" TOTAL_2="91" VAR="0.07297128159197125" WEIGHT="39.3569095618876"/><DICH_DATA CI_END="1.5293247129125374" CI_START="0.6047336312500958" EFFECT_SIZE="0.9616829451540195" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="33" LOG_CI_END="0.18449970650712552" LOG_CI_START="-0.218435878160739" LOG_EFFECT_SIZE="-0.016968085826806756" MODIFIED="2020-09-28 10:35:20 +0000" MODIFIED_BY="z1809101144386590162364906459144" ORDER="9" O_E="0.0" SE="0.23668635699721563" STUDY_ID="STD-Pelkonen-2011" TOTAL_1="363" TOTAL_2="360" VAR="0.05602043158861341" WEIGHT="60.6430904381124"/></DICH_OUTCOME><DICH_OUTCOME CHI2="0.47742296720422217" CI_END="2.8075733186677834" CI_START="1.4041890966280415" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.9855386780561861" ESTIMABLE="YES" EVENTS_1="86" EVENTS_2="43" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.4483311065103666" LOG_CI_START="0.14742559646346165" LOG_EFFECT_SIZE="0.2978783514869141" METHOD="MH" MODIFIED="2021-11-05 07:13:27 +0000" MODIFIED_BY="z1410211803125963335549909990550" NO="6" P_CHI2="0.48959197042946745" P_Q="1.0" P_Z="1.0424500809861075E-4" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="550" TOTAL_2="546" WEIGHT="100.0" Z="3.8804928537035286"><NAME>Short-term neurologic sequelae</NAME><GROUP_LABEL_1>Paracetamol</GROUP_LABEL_1><GROUP_LABEL_2>Standard treatment</GROUP_LABEL_2><GRAPH_LABEL_1>Favours paracetamol</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours std. treatment</GRAPH_LABEL_2><DICH_DATA CI_END="2.782331922551765" CI_START="1.1806972624562633" EFFECT_SIZE="1.8124821886577371" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="29" LOG_CI_END="0.44440893857259267" LOG_CI_START="0.07213855629342265" LOG_EFFECT_SIZE="0.2582737474330077" MODIFIED="2020-09-28 10:35:20 +0000" MODIFIED_BY="z1809101144386590162364906459144" ORDER="11" O_E="0.0" SE="0.21867346531889653" STUDY_ID="STD-Pelkonen-2011" TOTAL_1="363" TOTAL_2="360" VAR="0.047818084434574644" WEIGHT="67.47398565312314"/><DICH_DATA CI_END="4.234901053688201" CI_START="1.297989609879737" EFFECT_SIZE="2.3445378151260505" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="14" LOG_CI_END="0.6268432677153154" LOG_CI_START="0.11327121604681825" LOG_EFFECT_SIZE="0.3700572418810668" MODIFIED="2020-09-30 12:28:14 +0000" MODIFIED_BY="z1809101144386590162364906459144" ORDER="18" O_E="0.0" SE="0.3016747653727314" STUDY_ID="STD-Savonius-2020" TOTAL_1="187" TOTAL_2="186" VAR="0.09100766406269253" WEIGHT="32.526014346876856"/></DICH_OUTCOME><DICH_OUTCOME CHI2="0.8495674116068848" CI_END="4.036089907041587" CI_START="1.338666421383973" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="2.324430689920294" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.6059608319199647" LOG_CI_START="0.12667236984190447" LOG_EFFECT_SIZE="0.3663166008809346" METHOD="MH" MODIFIED="2021-11-05 07:13:27 +0000" MODIFIED_BY="z1410211803125963335549909990550" NO="7" P_CHI2="0.3566748234297462" P_Q="1.0" P_Z="0.0027357178274296516" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="450" TOTAL_2="451" WEIGHT="100.0" Z="2.995971743416732"><NAME>Long-term neurological sequelae</NAME><GROUP_LABEL_1>Paracetamol</GROUP_LABEL_1><GROUP_LABEL_2>Standard treatment</GROUP_LABEL_2><GRAPH_LABEL_1>Favours paracetamol</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours std. treatment</GRAPH_LABEL_2><DICH_DATA CI_END="3.8989471217776646" CI_START="0.7409751865940152" EFFECT_SIZE="1.6997126436781609" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="8" LOG_CI_END="0.5909473452480272" LOG_CI_START="-0.1301963352132906" LOG_EFFECT_SIZE="0.23037550501736825" MODIFIED="2020-09-28 10:35:20 +0000" MODIFIED_BY="z1809101144386590162364906459144" ORDER="61" O_E="0.0" SE="0.42360336762176803" STUDY_ID="STD-Molyneux-2014" TOTAL_1="87" TOTAL_2="91" VAR="0.17943981306050275" WEIGHT="46.38999054145993"/><DICH_DATA CI_END="6.028092465366802" CI_START="1.3616751854701512" EFFECT_SIZE="2.8650137741046833" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="9" LOG_CI_END="0.7801799053696314" LOG_CI_START="0.13407352315570426" LOG_EFFECT_SIZE="0.4571267142626678" MODIFIED="2020-09-28 10:35:20 +0000" MODIFIED_BY="z1809101144386590162364906459144" ORDER="35" O_E="0.0" SE="0.37952608719063397" STUDY_ID="STD-Pelkonen-2011" TOTAL_1="363" TOTAL_2="360" VAR="0.14404005085823268" WEIGHT="53.61000945854006"/></DICH_OUTCOME></COMPARISON><COMPARISON ID="CMP-002" MODIFIED="2020-12-04 12:29:10 +0000" MODIFIED_BY="z1809101144386590162364906459144" NO="2"><NAME>Immunoglobulins for acute bacterial meningitis</NAME><DICH_OUTCOME CHI2="0.0" CI_END="3.5950181600868567" CI_START="0.009779157833002605" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.1875" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" I2_Q="100.0" ID="CMP-002.01" LOG_CI_END="0.5557010885452137" LOG_CI_START="-2.0096985444177387" LOG_EFFECT_SIZE="-0.7269987279362623" METHOD="MH" MODIFIED="2020-10-13 18:50:08 +0000" MODIFIED_BY="06949243198815337251110526175424" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.2666315176694517" Q="2.1711768033605828E-32" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="15" TOTAL_2="14" WEIGHT="100.0" Z="1.1108532996208509"><NAME>Mortality</NAME><GROUP_LABEL_1>Immunoglobulins</GROUP_LABEL_1><GROUP_LABEL_2>Standard treatment</GROUP_LABEL_2><GRAPH_LABEL_1>Favours immunoglobulins</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours std. treatment</GRAPH_LABEL_2><DICH_DATA CI_END="3.595018160086855" CI_START="0.009779157833002613" EFFECT_SIZE="0.1875" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5557010885452135" LOG_CI_START="-2.009698544417738" LOG_EFFECT_SIZE="-0.7269987279362623" MODIFIED="2020-10-13 10:36:32 +0000" MODIFIED_BY="z1809101144386590162364906459144" ORDER="31" O_E="0.0" SE="1.5069284433354269" STUDY_ID="STD-Neu-1982" TOTAL_1="15" TOTAL_2="14" VAR="2.270833333333333" WEIGHT="100.0"/></DICH_OUTCOME><DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2020-12-04 12:29:10 +0000" MODIFIED_BY="z1809101144386590162364906459144" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="25" TOTAL_2="24" WEIGHT="0.0" Z="0.0"><NAME>Adverse events</NAME><GROUP_LABEL_1>Immunoglobulins</GROUP_LABEL_1><GROUP_LABEL_2>Standard treatment</GROUP_LABEL_2><GRAPH_LABEL_1>Favours immunoglobulins</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours std. treatment</GRAPH_LABEL_2><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2020-10-13 18:50:08 +0000" MODIFIED_BY="06949243198815337251110526175424" ORDER="78800" O_E="0.0" SE="0.0" STUDY_ID="STD-Neu-1982" TOTAL_1="15" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/><DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2020-10-13 18:50:08 +0000" MODIFIED_BY="06949243198815337251110526175424" ORDER="78801" O_E="0.0" SE="0.0" STUDY_ID="STD-Szenborn-1994" TOTAL_1="10" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/></DICH_OUTCOME></COMPARISON><COMPARISON ID="CMP-003" MODIFIED="2020-10-13 18:50:08 +0000" MODIFIED_BY="06949243198815337251110526175424" NO="3"><NAME>Heparin for acute bacterial meningitis</NAME><DICH_OUTCOME CHI2="0.0" CI_END="8.91387553868228" CI_START="0.586107554816801" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.2857142857142856" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.9500665658909636" LOG_CI_START="-0.23202268060762782" LOG_EFFECT_SIZE="0.3590219426416679" METHOD="MH" MODIFIED="2020-10-13 18:50:08 +0000" MODIFIED_BY="06949243198815337251110526175424" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.2338290482715173" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="7" TOTAL_2="8" WEIGHT="100.0" Z="1.1905532163862937"><NAME>Mortality</NAME><GROUP_LABEL_1>Heparin</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours heparin</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours std. treatment</GRAPH_LABEL_2><DICH_DATA CI_END="8.913875538682284" CI_START="0.5861075548168009" EFFECT_SIZE="2.2857142857142856" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.9500665658909637" LOG_CI_START="-0.2320226806076279" LOG_EFFECT_SIZE="0.3590219426416679" MODIFIED="2020-09-28 10:35:20 +0000" MODIFIED_BY="z1809101144386590162364906459144" ORDER="33" O_E="0.0" SE="0.6943650748294137" STUDY_ID="STD-MacFarlane-1977" TOTAL_1="7" TOTAL_2="8" VAR="0.4821428571428572" WEIGHT="100.0"/></DICH_OUTCOME></COMPARISON><COMPARISON ID="CMP-004" MODIFIED="2020-10-13 18:50:08 +0000" MODIFIED_BY="06949243198815337251110526175424" NO="4"><NAME>Pentoxifylline for acute bacterial meningitis</NAME><DICH_OUTCOME CHI2="0.0" CI_END="6.2982870356969025" CI_START="0.25092666534694297" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2571428571428571" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.7992224491202572" LOG_CI_START="-0.6004531848484336" LOG_EFFECT_SIZE="0.09938463213591178" METHOD="MH" MODIFIED="2020-10-13 18:50:08 +0000" MODIFIED_BY="06949243198815337251110526175424" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.7807541795230211" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="35" TOTAL_2="22" WEIGHT="100.0" Z="0.2783363443297698"><NAME>Mortality</NAME><GROUP_LABEL_1>Pentoxifylline</GROUP_LABEL_1><GROUP_LABEL_2>Control</GROUP_LABEL_2><GRAPH_LABEL_1>Favours pentoxifylline</GRAPH_LABEL_1><GRAPH_LABEL_2>Favours std. treatment</GRAPH_LABEL_2><DICH_DATA CI_END="6.2982870356969025" CI_START="0.25092666534694297" EFFECT_SIZE="1.2571428571428571" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.7992224491202572" LOG_CI_START="-0.6004531848484336" LOG_EFFECT_SIZE="0.09938463213591178" MODIFIED="2020-09-28 10:35:20 +0000" MODIFIED_BY="z1809101144386590162364906459144" ORDER="34" O_E="0.0" SE="0.8221763958993387" STUDY_ID="STD-Mart_x00ed_nez-de-Cuellar-2015" TOTAL_1="35" TOTAL_2="22" VAR="0.675974025974026" WEIGHT="100.0"/></DICH_OUTCOME></COMPARISON></ANALYSES_AND_DATA><FIGURES/><FEEDBACK/><APPENDICES/><EXTENSIONS/></COCHRANE_REVIEW>